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Abstract
Background: Metabolic syndrome has become a major public health challenge worldwide. The association
between metabolic syndrome and DNA methylation is of great research interest.
Results: We constructed a binomial model to investigate the association between a metabolic syndrome index and
DNA methylation in the Normative Aging Study. We applied the Iterative Sure Independence Screening (ISIS) method
with elastic net penalty to DNA methylation levels at 484,548 CpG markers from 659 human subjects, and
demonstrated that the screening step in ISIS can significantly improve the performance of the elastic net.
Conclusion: The proposed method identifies four CpGs which can be mapped to two biologically relevant and
functional genes. Identification of significant CpG markers may potentially have practical implications for disease
prevention and treatment.
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Background
DNA methylation is an epigenetic mechanism for regu-
lating gene expression. Chemically, it involves the modi-
fication of a cytosine (C) base by adding a methyl group.
In adult cells, DNA methylation typically occurs at CpG
sites, i.e., regions of DNA where cytosine (C) and gua-
nine (G) bases are linked by a phosphate. It can suppress
the expression of neighboring genes without changing
the underlying genetic sequence. Methylation has been
the most commonly studied epigenetic marker because of
its transmissibility during cell division as well as stability
in stored and processed blood samples. Deciphering the
DNA methylation code will help us predict and prevent
diseases [1, 2].
One of the major public health challenges worldwide
is the steadily increasing prevalence of metabolic syn-
drome that follows in the wake of society-wide changes
such as urbanization, surplus energy intake, increasing
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obesity and sedentary lifestyle. The International Diabetes
Federation estimates that one-quarter of the world’s adult
population has metabolic syndrome [3]. Metabolic syn-
drome is significantly associated with risks of developing
cardiovascular disease and diabetes [4]. Our goal is to
explore the associations betweenmetabolic syndrome and
ultra-high dimensional DNA methylation markers.
Our motivating example is the Normative Aging Study
(NAS), where methylation levels from 484,548 CpG sites
were measured in 659 subjects. This paper describes our
application of an Iterative Sure Independence Screening
(ISIS) method [5, 6] with elastic net penalty [7] to address
the ultra-high dimensionality and correlation structure of
these methylation markers.
The structure of the paper is as follows. In “Results”
section, we use simulations to evaluate the performance
of our method and apply it to the NAS data. Then, we give
the clinical interpretation of our findings in “Discussion”
section. In “Discussion” section, we demonstrate the
results of using our method on the NAS data. Finally,
in “Conclusions” section, we conclude with a summary
discussion and possible directions for future research.
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Methods
Data
The Normative Aging Study (NAS) is a longitudinal
cohort study established in 1963 by the Department of
Veterans Affairs [8]. With an initial cohort of 2280 healthy
men, NAS is an ongoing project to study the effects of
aging on various health issues. Eligibility criteria at enroll-
ment included veteran status; residence in the Boston
area; ages 21-80; and no history of hypertension, heart
disease, cancer, diabetes, or other chronic health condi-
tions. From 1963 to 1999, 981 participants died and 470
were lost to follow up. Participants were recalled for clin-
ical examinations every 3-5 years. Between March 1999
and December 2013, 802 (96.7%) of the remaining 829
active participants agreed to donate blood, 686 of whom
were randomly selected and profiled using the Illumina
450K BeadChip array at up to three follow-up visits sepa-
rated by a median time interval of 3.5 years (IQR 3.1-5.7).
We excluded participants who 1) were non-white or had
missing information on race to minimize potential con-
founding effects of genetic ancestry, or 2) had leukemia
diagnosed prior to or during the year of their blood
draw as their blood methylation profiles could have been
affected. A total of 664 individuals and samples collected
at their first blood draw remained for analysis.
DNA samples were extracted from buffy coat using the
QIAamp DNA Blood Kit (QIAGEN, Valencia, CA, USA).
A total of 500 ng of DNA was used to perform bisul-
fite conversion using the EZ-96 DNA Methylation Kit
(Zymo Research, Orange, CA, USA). To limit chip and
plate effects, a two-stage age-stratified algorithmwas used
to randomize samples and ensure similar age distribu-
tions across chips and plates. We randomized 12 samples
(sampled across all age quartiles) to each chip, then ran-
domized chips to plates (eight chips per plate). Quality
control analysis was performed to remove samples and
probes where > 1% had a detection p-value > 0.05. The
remaining samples were preprocessed using the Illumina-
type background correction [9] and normalized with the
dye-bias [10] and BMIQ [11] adjustments.
Beta values for DNA methylation level were calculated
as the ratio of the methylated probe intensity to the over-
all intensity, which can be interpreted as the approximate
percentage of methylation. Beta values had a range of 0 to
1, but were severely compressed at the extremes. Conse-
quently, Beta values were converted to M-values through
logit transformation, providing insight into the distribu-
tion ofmethylation across the genome difficult to visualize
with the raw value [12]. M-values were then used in our
analysis. The K-nearest neighbors algorithm was applied
in the space of CpG sites to impute missing methyla-
tion values [13]. Batch and potential confounding effects
of white blood cell subtypes as estimated by Houseman’s
method [14] were corrected for using ComBat [15].
Metabolic syndrome is defined as whether at least three
of the following five conditions are satisfied (y = 1) or not
(y = 0):
• Abdominal obesity (waist circumference > 102cm for
men);
• High fasting blood sugar (≥ 100mg/dl) or currently
taking diabetes medication;
• Reduced HDL cholesterol (< 40mg/dl for men) or
currently taking cholesterol medication;
• Hypertension (systolic blood pressure > 130mmHg
or diastolic blood pressure > 85mmHg) or currently
taking antihypertensive medication;
• Hypertriglyceridemia (≥ 150mg/dl) or currently
taking medication for hypertriglyceridemia.
To increase power, in this paper we created a metabolic
syndrome index as the number of above satisfied con-
ditions. Five subjects with missing data for the above
metabolic syndrome conditions are excluded. The final
working dataset includes methylation levels of 659 sub-
jects measured at 484,548 CpG sites.
Analytical method
Two issues complicate the analysis of DNA methylation
data. First, the DNA methylation markers are ultra-high
dimensional, i.e., p  n. Second, DNA methylation levels
measured from probes in close proximity are correlated
[16]. For example, in the NAS data, the co-methylation
correlation could be as high as 0.98 as the samples were
free of cell culture-induced epigenetic changes. It is thus
imperative to account for ultra-high dimensionality and
high correlation simultaneously. In this paper, we adopt
the ISIS approach, an iterative two-step procedure com-
bining the screening and variable selection steps.
Fan and Lv [5] proposed the sure independence screen-
ing (SIS) and Iterative SIS (ISIS) methods. Later, Fan et al.
[6] extended ISIS to the general pseudo-likelihood frame-
work. In SIS, all predictor variables are first ranked based
on their Pearson correlations with the response variable.
Then, model selection is conducted using a predefined
number of the most highly correlated variables. The goal
for ISIS is to rescue some variables among missed vari-
ables iteratively by ranking marginal correlations with
residuals. It can detect important predictors which are
marginally uncorrelated by themselves but jointly cor-
related with the response. Least absolute shrinkage and
selection operator (LASSO), smoothly clipped absolute
deviation (SCAD), Dantzig selector, and other methods
are used for model selection in [5, 6]. For the analysis in
this paper, the elastic net penalty is considered to account
for correlated methylation markers.
As a compromise between the ridge and LASSO meth-
ods, elastic net enjoys a similar sparsity as LASSO but
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shrinks together the coefficients of correlated predictors
like ridge. It also offers considerable computational
advantages over the Lq penalties where q ∈ (0, 1)
[7, 17, 18]. The elastic net penalty has been used widely
to conduct model selection in epigenetic studies. For
example, [19] built a predictive model of aging using elas-
tic net combined with a bootstrap approach. [20] also
used the elastic net regression model to predict epige-
netic age across a broad spectrum of human tissues and
cell types.
The screening step in ISIS could reduce the ultra-high
dimensional covariates to a manageable number by iden-
tifying markers which are marginally correlated with the
outcome. As a result, in the variable selection step we can
tackle the correlation issue in a much smaller covariate
space, in which elastic net is expected to performwell. The
iterative procedure can recover variables missed at the
screening step. Hereafter we choose a weight coefficient
of w = 0.5, i.e., half LASSO and half ridge penalties.
We will use a binomial model for the ordinal metabolic
syndrome index {0, 1, . . . , 5} as a response variable (y) and
methylation levels as predictor variables (x). n is a sam-
ple size and πi is a probability of having any of the above
metabolic syndrome conditions for the ith subject.
yi ∼ Binomial(5,πi) for i = 1, · · · , n. (1)































All methods were implemented in the R programming
language. See https://github.com/GraceYoon/ISIS_EN for
the R source code and an simple example.
Results
Simulation
We will illustrate our method by simulation. R is inca-
pable of generating an ultra-high dimensional correlation
matrix (484,548 by 484,548). Therefore, in a similar fash-
ion to [21], the real NAS methylation data set is used
as an n × p design matrix (X = (x1, x2, . . . , xn)T =
(X1,X2, . . . ,Xp)) to take the correlation structure among
covariates into account. We randomly generate y from a
binomial distribution with parameters m = 5 and π(x).
Then, each element of y = (y1, . . . , yn) can take an integer
value ∈ {0, 1, 2, 3, 4, 5} for the metabolic syndrome index.
This yields simulation data the same size as the NAS
dataset: n = 659 and p = 484, 548. We used the following
coefficients as true parameters β = (β1,β2, . . . ,βp)T in
the simulation setting which are the estimated coefficients
in the actual data analysis:
(β474287,β126564,β38487,β325547) = (6.6, 2.2, 3.5,−6.3) ,
βj = 0 for all other j′s.
For ISIS, we need to choose a proper submodel size (d)
in the screening step, which should be large enough to
include the true significant coefficients with a probability

















for a continuous outcome, where n is a
sample size. Since y takes integer values from 0 to 5, we












The study by Hannum [19] implemented the elastic net
penalty on bootstrap samples, and selected CpG markers
which were presented for more than half of all bootstraps.
Before that, [22] and [23] proposed Bolasso (bootstrap-
enhanced lasso): use LASSO for bootstrapped replications
of a given sample, and intersect the supports of the LASSO
bootstrap estimates. A softer version of Bolasso selects
those variables which are present in a high proportion of
bootstrap replications. These papers showed that Bolasso
leads to consistent model selection. Along these lines,
we generated 100 bootstrap samples of the same size
(n = 659), and used ISIS with elastic net penalty to
select the significant methylation markers in each boot-
strap sample. Here we show the results from ISIS with
elastic net, using two different choices of d on 100 boot-
strap samples. For comparison, we also list the results
estimated by elastic net only (without the screening step)
in Table 1.
In all cases, the four nonzero coefficient variables are all
correctly selected the most often. However, the elastic net
only method (without screening) identified 6 additional
false markers (70756, 320060, 270466, 88446, 278727,
56822) in at least half of all bootstrap samples, indicat-
ing a poor performance against false positives. In contrast,
ISIS with the elastic net has a much wider gap in selected
frequencies between true and redundant variables, and
none of the redundant markers are selected in more than
1/3 of the 100 bootstrap samples. The results from the two
different sizes of d are consistent with one another.
We repeated this process 5 times (5 datasets with 100
bootstrap samples for each dataset) with consistent results
(available upon request). Moreover, we have conducted
simulations with varying weights w = 0.25, 0.75 and 1
(LASSO), under the same simulation setting (available
upon request). The results show that a larger w results in a
sparser model when there is no screening step. However,
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Table 1 Simulation results
Elastic net only
ISIS with elastic net
d = 50 d = 25
j freq j freq j freq
474287 100 474287 100 474287 100
325547 96 126564 84 126564 87
126564 84 38487 68 38487 66
38487 76 325547 65 325547 54
70756 72 359976 26 359976 18
320060 64 384921 21 384921 18
270466 56 258231 19 425056 14
88446 55 425056 18 258231 12
278727 55 86441 15 292919 11
56822 53 329494 15 324153 11
35978 49 320139 14 329494 11
30499 48 90855 13 264984 9
322963 45 233845 13 320139 9
350509 45 324153 13 430210 8
61038 42 16510 12 358567 7
213264 42 361987 12 16510 6
223673 42 46090 11 44790 6
381178 42 264984 11 46090 6
452998 41 349498 11 233845 6
36696 40 86525 9 86525 5
there is virtually no change for different w values in ISIS,
demonstrating the robustness of ISIS with respect to the
weight chosen.
Application to NAS data
Similar to the Simulation Section, we generated 100 boot-
strap samples from the original data. Table 2 shows the
selected markers and frequencies of their selection in
the model out of 100 bootstrap samples. Among 484,548
CpGs, our method identifies four CpG sites as being
strongly associated with metabolic syndrome.
We also compare our results to those from the elas-
tic net only method [19]. As shown in the left column
of Table 2, this method identifies 19 CpGs that appear
in more than half of the bootstrap samples, many more
than the 4 identified by ISIS. For example, the 4th most-
selected CpG by the elastic net only method, X219492, is
listed with very low frequency in both columns represent-
ing our method. The iterative screening step in ISIS can
therefore improve the performance of elastic net by reduc-
ing the chance of false positives in ultra-high dimensional
data.
To compare the performances of the resulting mod-
els, we used 5-fold cross validation to calculate AUC
Table 2 NAS data results
Elastic net only
ISIS with elastic net
d = 50 d = 25
j freq j freq j freq
474287 98 474287 91 474287 91
325547 96 126564 67 126564 57
126564 91 38487 46 38487 54
219492 84 325547 46 325547 53
38487 80 12205 20 12205 30
36730 71 141722 17 467369 24
131967 66 467369 16 141722 22
12205 65 351200 15 213684 17
248438 64 147068 13 402549 16
95930 62 402549 12 433494 16
402549 60 193471 11 55087 15
207644 59 213684 11 147068 15
400141 59 268623 11 33489 14
256046 54 55087 10 343324 14
79189 53 104428 10 206869 13
467369 53 433494 10 95930 12
408183 52 95930 9 193471 12
416044 52 219492 9 219492 12
317479 51 248438 9 248438 12
478992 49 206869 8 317479 12
(Area Under the Curve) of ROC curves. Four folds were
taken as training data, which we used to build our model.
The remaining fold was used as a test datum to calcu-
late AUC. Since we used metabolic syndrome index as a
count variable y, we measured multiclass AUC proposed
by [24] and the average value over 5 folds is reported.
We also present the mean AUC value for binary out-
comes for the standard definition of metabolic syndrome,
i.e., whether at least three of the five conditions are sat-
isfied (y = 1) or not (y = 0). These results are shown
in Table 3. We note that even though our model has
selected many fewer variables (due to the reduced sam-
ple size in the training data), its AUC is higher than
the elastic net only method which is subject to false
positives.
Table 3 5-fold cross validation for AUC
Elastic net ISIS, d=50 ISIS, d=25
The number of selected variables
9.6 1.6 1.6
(2.51) (0.55) (0.55)
Average of AUC 0.6011 0.6219 0.6197
Average of multiclass AUC 0.6249 0.6358 0.6441
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Discussion
Associated gene information for the four CpG mark-
ers selected by ISIS with the elastic net method is
shown in Table 4. The first three CpGs (cg27243685,
cg06500161 and cg01881899) are located in close prox-
imity to one another in the same gene: ABCG1. Two,
cg06500161 and cg01881899, are at the South Shore
and North Shelf of the same CpG Island, respectively.
Pfeiffer et al. [25] identified that higher methylation
at cg06500161 was associated with lower high-density
lipoprotein (HDL) cholesterol and higher triglycerides.
The coefficient estimates (βˆ) in Table 4 are consistent
with this association. Moreover, methylation levels in
cg06500161 and cg27243685 were found to be nega-
tively associated with ABCG1 transcripts. Hidalgo et al.
[26] showed associations between the methylation sta-
tus of cg06500161 and fasting insulin as well as with
HOMA-IR (homeostasis model assessment of insulin
resistance), a surrogate marker of insulin resistance. Ding
et al. [27] reported that it is the most strongly corre-
lated CpG site with BMI among expression-associated
methylation sites within one megabase of any cholesterol
metabolism network. Our results are also consistent with
functional studies of ABCG1 expression. Kennedy et al.
[28] and Frisdal et al. [29] identified that higher expres-
sion of ABCG1 is associated with increased fat mass,
and that deficiency of ABCG1 reduces triglyceride stor-
age. Together, these findings suggest that ABCG1 expres-
sion plays a key role in metabolic syndrome, and that
DNA methylation may be substantially involved in this
pathway.
cg17901584 is located in the TSS1500 region (from -200
to -1500 nucleotides upstream of transcription start site)
in the promoter of the gene DHCR24. Drzewinska et al.
[30] showed that methylation of the DHCR24 promoter
region affects transcriptional efficiency. DNA methyla-
tion mediates transcriptional repression via binding of
the methylated DNA-binding protein or preserves the
binding of transcription factors to their motifs. In the
Bloch (Cholesterol Biosynthesis) pathway, desmosterol is
converted into cholesterol by DHCR24 in the final step.
Zerenturk et al. [31] and Luu et al. [32] found that modu-
lating DHCR24 activity alters levels of desmosterol which
further reduces cellular cholesterol status. Thus, DNA
Table 4 Genes associated with the most frequently selected
CpG markers
j NAME CHR REFGENE REFGENE GROUP βˆj
474287 cg27243685 21 ABCG1 Body; 5’UTR 6.64901
126564 cg06500161 21 ABCG1 Body 2.20140
38487 cg01881899 21 ABCG1 Body 3.49123
325547 cg17901584 1 DHCR24 TSS1500 −6.31737
methylation may also affect metabolic syndrome via path-
ways related to DHCR24.
Conclusions
Using the ISIS method with the elastic net penalty,
our study found four important CpGs associated with
the metabolic syndrome index from ultra-high dimen-
sional DNA methylation markers. They are located in
two biologically relevant and functional genes. Adding the
screening step iteratively to the variable selection method
is shown to improve its performance against false posi-
tives. In conclusion, the two criteria we used: 50% and
a gap in the frequencies in the bootstrap samples yield
satisfactory selection results against false positives.





in the screening step and select the value of c from a
grid using the cross-validated prediction error. The adap-
tive choice of tuning parameter c may lead to improved
performance when the sample size is not too large.
In NAS, methylation levels were measured up to three
times with a median interval of 3.5 years. Our method
could be extended to longitudinal data analysis along the
way of [33]. Moreover, we are interested in mediation
analysis to determine whether methylation mediates the
path from intervention (e.g. diet, physical exercise) to
health outcomes, thereby helping understand the under-
lying biological mechanisms of interventions [34].
This analysis is limited to white male subjects in the
NAS study. In the future we will validate our results
using other cohorts, e.g., the Coronary Artery Risk Devel-
opment in Young Adults Study (CARDIA), and further
examine the relation between DNA methylation and
metabolic syndrome in young and middle-aged, mixed-
gender, and multi-racial populations.
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